Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radara is a micro-channelling transdermal patch system developed by Innoture for aesthetic and cosmetic skin treatments. The system consists of flexible, ergonomically shaped patches embedded with 3D-printed microscopic solid microneedles made from medical-grade polymer. When applied to the skin, these microneedles create thousands of painless micro-channels in the stratum corneum, significantly enhancing the penetration of a high-purity hyaluronic acid (HA) serum into the epidermis. The product is specifically designed to target signs of aging around the eyes, such as crow's feet and fine lines, and is intended for a four-week treatment regimen involving daily five-minute applications. Clinical studies have demonstrated a reduction in wrinkle depth by approximately 35% after 28 days of use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Radara.